Contraception Choice Among Those Seeking Abortion for Fetal Indication or Management of Pregnancy Loss.
Autor: | Meurice ME; Department of Obstetrics and Gynecology, University of California, Irvine, Orange, and the Department of Medicine, University of California, Irvine, School of Medicine, Irvine, California., Lovio M, Chang JJ, Perry R |
---|---|
Jazyk: | angličtina |
Zdroj: | Obstetrics and gynecology [Obstet Gynecol] 2021 Apr 01; Vol. 137 (4), pp. 606-611. |
DOI: | 10.1097/AOG.0000000000004315 |
Abstrakt: | Objective: To compare contraception choices of those who are undergoing abortion procedures for fetal indications or surgical management of pregnancy loss with those who are having abortions for another indication. Methods: We conducted a cross-sectional study at University of California, Irvine, from December 1, 2017, through December 31, 2018, and included gestational ages up to 24 0/7 weeks. We abstracted data from electronic medical records and analyzed them using descriptive statistics, χ2, Fisher exact tests, and a multivariate logistic regression model for primary outcome (whether a contraception method was chosen) and secondary outcome (whether a long-active reversible contraception was chosen). Results: Those with fetal indication were less likely to choose contraception than those with other indication (68/134, 50.7% vs 142/158, 89.9%, P<.001), and among those choosing contraception those with fetal indication were less likely to choose long-acting reversible contraception (LARC) (19/68, 27.9% vs 94/142, 66.2%, P<.001). Differences remained significant in multivariable analysis that controlled for age, gestational age in weeks, race, parity, procedure type, and comorbidities (among those with fetal indication for choosing any contraception: adjusted odds ratio [aOR] 0.11, 95% CI 0.05-0.23; choosing LARC: aOR 0.17, 95% CI 0.07-0.39). Conclusion: Only half of those seeking abortion for a fetal indication or surgical management of pregnancy loss were interested in contraception. Competing Interests: Financial Disclosure The authors did not report any potential conflicts of interest. (Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |